Additionally, Biocon has obtained an Establishment Inspection Report (EIR) from the US FDA for its greenfield API facility in Visakhapatnam, clearing the way for commercial supplies to the US market.
Biocon in a regulatory filing on Tuesday said it sold 80,00,000 equity shares of its subsidiary Syngene International Ltd. (Syngene) in the open market for Rs.686 crore through a block deal.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback